Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.
Lee J, Park JO, Kim WS, Lee SI, Song SY, Lim DH, Choi SH, Heo JS, Lee KT, Lee JK, Kim K, Jung CW, Im YH, Lee MH, Kang WK, Park K.
Lee J, et al. Among authors: im yh.
Oncology. 2004;66(1):32-7. doi: 10.1159/000076332.
Oncology. 2004.
PMID: 15031596
Clinical Trial.